Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites
Keywords: Diffuse large B cell lymphoma; Extranodal involvement; Waldeyer's ring; GCB phenotype; Rituximab;